Illumina Rebuffs $5.7B Roche Bid With Poison Pill
Gene sequencing company Illumina Inc. moved quickly Thursday to stymie a $5.7 billion hostile takeover bid by Swiss drugmaker Roche Holding Ltd., adopting a poison pill plan just one day after...To view the full article, register now.
Already a subscriber? Click here to view full article